What question did this study set out to answer?

To compare rates of TIVAD infections between hematology and oncology patients.

March 30, 2026The Journal of Vascular Access0 citations

Totally implanted vascular access devices-related infections in oncology and hematology: A retrospective single-center study

KMKlaudia MisterkaChildren's Memorial Health Institute MLMaciej LatosMedical University of Warsaw

Key Points

To compare rates of TIVAD infections between hematology and oncology patients.
Retrospective single-center study
Analysis of infection rates in hematology versus oncology patients
Comparison of clinical outcomes in distinct patient populations.
Hematology patients had a higher incidence of TIVAD infections than oncology patients.
Significant clinical differences observed between solid tumours and hematological malignancies.

Abstract

Hematology patients were more likely to have TIVAD infections than oncology patients. In most studies, patients with solid tumours and hematological malignancies were analysed together, despite significant clinical differences. Therefore, we decided to analyze these two groups of patients separately.

Ask AI

Helpful

Bookmark

View Full Paper